Ledger.Open graph →
SEC Form D · filed February 26, 2019

Omniome, Inc

Offering
$40.0M
Sold
$40.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

Ken S. Song, M.D., Ph.D · SAN DIEGO, CAExec · DirectorDavid S. Mullarkey · SAN DIEGO, CAExec · DirectorArnold S. Oliphant · SAN DIEGO, CAExecKim S. Kamdar, Ph.D · SAN DIEGO, CADirectorMichael S. Yi · SAN DIEGO, CADirectorKelly S. Perez · SAN DIEGO, CAExecDan S. Zabrowski · SAN DIEGO, CADirectorJeffrey Batton · Bozeman, MTExec · DirectorJeffry Flowers · Boston, MADirectorMichael Bayer · Boston, MAExecMark A. Manetti · WEXFORD, PAExec · DirectorWilliam Stoddart · Bozeman, MTExecAlexander L. Papadimitriou · Boston, MADirectorN. L. Shipley · Boston, MADirectorBoris S. Nikolic, M.D · San Diego, CADirectorJohn S. Murphy, Ph.D · San Diego, CAExecDavid S. Cruikshank · San Diego, CADirectorAdrienne O'Neal · Las Vegas, NVExec · DirectorMike Harman · Las Vegas, NVExecJoshua J. Horowitz · Boston, MAExec · DirectorJacquelyn Barry Hamilton · Boston, MADirectorCharlotte Hervouet · Guernsey, United KingdomExecGeorge Papamarkakis · London, United KingdomDirectorCharlotte Hervouet · Guemsey, United KingdomDirectorBoris S. Nikolic, M.D · San Diego, CADirectorJohn S. Murphy, Ph.D · San Diego, CAExecDavid S. Cruikshank · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗